Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)

CNY 9.12

(-0.44%)

Market Cap (In CNY)

4.91 Billion

Revenue (In CNY)

1.6 Billion

Net Income (In CNY)

-200.8 Million

Avg. Volume

5.16 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.62-13.68
PE
-
EPS
-
Beta Value
0.324
ISIN
CNE1000024Z7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jian Hua Bao
Employee Count
-
Website
https://www.fushine.cn
Ipo Date
2015-12-22
Details
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.